Joseph Shulman

2021

In 2021, Joseph Shulman earned a total compensation of $1.8M as Chief Technical Officer at RHYTHM PHARMACEUTICALS.

Compensation breakdown

Non-Equity Incentive Plan$157,223
Option Awards$716,625
Salary$386,250
Stock Awards$516,545
Other$11,600
Total$1,788,243

Shulman received $716.6K in option awards, accounting for 40% of the total pay in 2021.

Shulman also received $157.2K in non-equity incentive plan, $386.3K in salary, $516.5K in stock awards and $11.6K in other compensation.

Rankings

In 2021, Joseph Shulman's compensation ranked 6,487th out of 12,415 executives tracked by ExecPay. In other words, Shulman earned more than 47.7% of executives.

ClassificationRankingPercentile
All
6,487
out of 12,415
48th
Division
Manufacturing
2,778
out of 5,501
50th
Major group
Chemicals And Allied Products
1,225
out of 2,371
48th
Industry group
Drugs
1,092
out of 2,092
48th
Industry
Pharmaceutical Preparations
792
out of 1,542
49th
Source: SEC filing on April 27, 2023.

Shulman's colleagues

We found four more compensation records of executives who worked with Joseph Shulman at RHYTHM PHARMACEUTICALS in 2021.

2021

David Meeker

RHYTHM PHARMACEUTICALS

Chief Executive Officer

2021

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Financial Officer

2021

Yann Mazabraud

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of International

2021

Jennifer Chien

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of North America

News

You may also like